ALCHEMY PHARMATECH LIMITED

🌳Matureactive

07912825 · ltd · incorporated 2012-01-17

Investment thesis

Established operating company — standard diligence applies, no dominant angle.

Why interesting: Live, filing, normal profile.

Why risky: No standout signals in either direction.

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Mar 2025

Net worth

—

book net assets

Opportunity

79/100

Strong

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Research and experimental development on biotechnology

Sector: Professional, scientific & technical

Investor take

Pursue

Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 79/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (79/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

8 officers (3 active, 8 linked, 6 with DOB)

Ownership & PSC

2 active PSC(s) of 3 total, 3 with control declared

Director network

1 connected companies via shared directors

Filing history

66 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

79/100Strong

PassWatchWorth a lookStrongExceptional

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality

Active, clean filings, stable charge profile.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts

Cash

—

Net Worth

—

Current Assets

—

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown

Metric	2025-03-31	2024-03-31
Average employees	0	100

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filings

Last 180 days

filings

• 3 persons-with-significant-control
• 1 accounts
• 1 confirmation-statement

Counts from Companies House filing history.

Corporate timeline (32 events)Click to expand

2026-03-23
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2026-02-18
📄
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-02-18
📄
change-to-a-person-with-significant-control
persons-with-significant-control · PSC05
2026-02-18
📄
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC01
2025-11-10
📄
change-person-secretary-company-with-change-date
officers · CH03
2024-12-27
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2024-07-09
📍
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2023-12-22
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2023-06-23
📄
termination-director-company-with-name-termination-date
officers · TM01
2023-06-23
📄
appoint-person-director-company-with-name-date
officers · AP01
2023-06-13
➕
GEORGE, Michael Edward appointed
director
2023-06-13
➖
HARRISON, Peter Ian resigned
director
2023-05-02
📄
second-filing-of-confirmation-statement-with-made-up-date
confirmation-statement · RP04CS01
2023-04-28
➖
GEORGE, Michael Edward resigned
director
2023-04-28
📄
termination-director-company-with-name-termination-date
officers · TM01
2023-04-26
➕
GEORGE, Michael Edward appointed
director
2023-04-26
📄
appoint-person-director-company-with-name-date
officers · AP01
2023-04-25
📄
capital-allotment-shares
capital · SH01
2022-12-20
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2021-12-20
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2020-08-18
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2019-05-29
📄
accounts-with-accounts-type-micro-entity
accounts · AA
2018-01-18
➖
NORRIS, Michael John resigned
director
2016-09-30
➖
NWF4B DIRECTORS LIMITED resigned
corporate-director
2013-03-31
➕
CLAYBOROUGH, Robert, Dr appointed
director
2013-03-31
➕
NORRIS, Michael John appointed
director
2013-03-31
➖
SAVAGE, Bruce resigned
director
2012-04-19
➕
NWF4B DIRECTORS LIMITED appointed
corporate-director
2012-01-18
➕
HARRISON, Joan appointed
secretary
2012-01-17
🏢
Company incorporated
As ALCHEMY PHARMATECH LIMITED
2012-01-17
➕
HARRISON, Peter Ian appointed
director
2012-01-17
➕
SAVAGE, Bruce appointed
director

Owner dependency

66/100

High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS

+Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
+Senior director age: Director aged approximately 60 — approaching natural succession window.

Succession & seller-readiness

59/100

Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS

secondaryFounder aged 58+: Senior director is approximately 60. Early succession window.
secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
secondary12+ year tenure: Director in role 13 years.
supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

North West Fund For Biomedical Lp holds 25-50% — a significant corporate investor but not a controlling parent.

🏛️

North West Fund For Biomedical Lp

Corporate parent · holds 25-50% shares

significant stake

⬇

ALCHEMY PHARMATECH LIMITED

This company · 07912825

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

2 active beneficial owners

Name	Shares	Voting rights	Nature of control	Notified
Mrs Joan Harrison Individual · British · DOB 07/1942 · age 84	25–50%	25–50%	25-50% shares · 25-50% voting	07/01/2026
North West Fund For Biomedical Lp Corporate entity	25–50%	25–50%	25-50% shares · 25-50% voting	06/04/2016

1 historic (ceased) PSC

Mr Ian Peter Harrisonceased 07/01/2026· 25-50% shares

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · OX postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
AIRA LIMITED→ 11475919 · est 2018 · no financials extracted	—	—	—	—	7y	—	—
AJ RACING LTD→ 13774794 · est 2021 · no financials extracted	—	—	—	—	4y	—	—
AJD TAX LIMITED→ 13320224 · est 2021 · no financials extracted	—	—	—	—	5y	—	—
AJV CONSULT LIMITED→ 15601750 · est 2024 · no financials extracted	—	—	—	—	2y	—	—
AK DESIGN ATELIER LIMITED→ 14134836 · est 2022 · no financials extracted	—	—	—	—	3y	—	—
AKKA SERVICES LTD→ 14438778 · est 2022 · no financials extracted	—	—	—	—	3y	—	—
AKSWARD LIMITED→ 05433208 · est 2005 · no financials extracted	—	—	—	—	20y	—	—
AL3D LIMITED→ 07915303 · est 2012 · no financials extracted	—	—	—	—	14y	—	—
ALATE BUSINESS GROWTH LTD→ 11709929 · est 2018 · no financials extracted	—	—	—	—	7y	—	—
ALBION CONSULT LIMITED→ 11787216 · est 2019 · no financials extracted	—	—	—	—	7y	—	—
ALDER DEMAIN & AKERS LIMITED→ 08787015 · est 2013 · no financials extracted	—	—	—	—	12y	—	—
ALDWIN LTD→ 17009202 · est 2026 · no financials extracted	—	—	—	—	—	—	—

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2012-01-17

Jurisdictionengland-wales

Primary SIC72110 — Research and experimental development on biotechnology

Registered office

9 Watcombe Road

Watlington

OX49 5QJ

England

Filing status

Accounts

Next due: 2026-12-31

Last made up to: 2025-03-31

Confirmation statement

Next due: 2027-01-23

Last: 2026-01-09

Officers (3 active · 5 resigned)

HARRISON, Joan→

secretary · appointed 2012-01-18

View their other companies + combined net worth →

Active

CLAYBOROUGH, Robert, Dr→

director · ~60y · appointed 2013-03-31

View their other companies + combined net worth →

Active

GEORGE, Michael Edward→

director · ~60y · appointed 2023-06-13

View their other companies + combined net worth →

Active

GEORGE, Michael Edward→

director · ~60y · appointed 2023-04-26 · resigned 2023-04-28

Resigned

HARRISON, Peter Ian→

director · ~83y · appointed 2012-01-17 · resigned 2023-06-13

Resigned

NORRIS, Michael John→

director · ~62y · appointed 2013-03-31 · resigned 2018-01-18

Resigned

SAVAGE, Bruce→

director · ~78y · appointed 2012-01-17 · resigned 2013-03-31

Resigned

NWF4B DIRECTORS LIMITED→

corporate-director · appointed 2012-04-19 · resigned 2016-09-30

Resigned

Click a director name to see their full track record across all companies.

Recent filings (66 total)

accounts-with-accounts-type-micro-entity

accounts · AA

2026-03-23

confirmation-statement-with-updates

confirmation-statement · CS01

2026-02-18

cessation-of-a-person-with-significant-control

persons-with-significant-control · PSC07

2026-02-18

change-to-a-person-with-significant-control

persons-with-significant-control · PSC05

2026-02-18

notification-of-a-person-with-significant-control

persons-with-significant-control · PSC01

2026-02-18

change-person-secretary-company-with-change-date

officers · CH03

2025-11-10

confirmation-statement-with-no-updates

confirmation-statement · CS01

2025-01-23

accounts-with-accounts-type-micro-entity

accounts · AA

2024-12-27

change-registered-office-address-company-with-date-old-address-new-address

address · AD01

2024-07-09

confirmation-statement-with-no-updates

confirmation-statement · CS01

2024-01-23

accounts-with-accounts-type-micro-entity

accounts · AA

2023-12-22

termination-director-company-with-name-termination-date

officers · TM01

2023-06-23

appoint-person-director-company-with-name-date

officers · AP01

2023-06-23

second-filing-of-confirmation-statement-with-made-up-date

confirmation-statement · RP04CS01

2023-05-02

termination-director-company-with-name-termination-date

officers · TM01

2023-04-28